中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
11期
106-107
,共2页
稳心颗粒%美托洛尔%室性心律失常%临床疗效
穩心顆粒%美託洛爾%室性心律失常%臨床療效
은심과립%미탁락이%실성심률실상%림상료효
Wenxinkeli%Metoprolol%Ventricular arrhythmias%Clinical efficacy
目的:探析稳心颗粒联合美托洛尔治疗室性心律失常的临床疗效。方法选取该院2013年1月—2014年11月收治的98例室性心律失常患者,对其临床资料进行回顾性分析,并在患者知情同意的情况下将其分为治疗组和对照组,治疗组给予稳心颗粒联合美托洛尔,对照组单独使用美托洛尔,分析两组患者的治疗效率及不良反应情况。结果经治疗后,治疗组患者显效27例,有效20例,其总有效率为(47/49)95.92%;对照组患者显效21例,有效19例,其总有效率为(40/49)81.63%;两组相比较差异有统计学意义(P<0.05);两组患者在不良反应上差异无统计学意义(P>0.05)。结论稳心颗粒联合美托洛尔治疗室性心律失常的临床疗效较好,可以显著改善患者临床症状,不良反应少,值得应用。
目的:探析穩心顆粒聯閤美託洛爾治療室性心律失常的臨床療效。方法選取該院2013年1月—2014年11月收治的98例室性心律失常患者,對其臨床資料進行迴顧性分析,併在患者知情同意的情況下將其分為治療組和對照組,治療組給予穩心顆粒聯閤美託洛爾,對照組單獨使用美託洛爾,分析兩組患者的治療效率及不良反應情況。結果經治療後,治療組患者顯效27例,有效20例,其總有效率為(47/49)95.92%;對照組患者顯效21例,有效19例,其總有效率為(40/49)81.63%;兩組相比較差異有統計學意義(P<0.05);兩組患者在不良反應上差異無統計學意義(P>0.05)。結論穩心顆粒聯閤美託洛爾治療室性心律失常的臨床療效較好,可以顯著改善患者臨床癥狀,不良反應少,值得應用。
목적:탐석은심과립연합미탁락이치료실성심률실상적림상료효。방법선취해원2013년1월—2014년11월수치적98례실성심률실상환자,대기림상자료진행회고성분석,병재환자지정동의적정황하장기분위치료조화대조조,치료조급여은심과립연합미탁락이,대조조단독사용미탁락이,분석량조환자적치료효솔급불량반응정황。결과경치료후,치료조환자현효27례,유효20례,기총유효솔위(47/49)95.92%;대조조환자현효21례,유효19례,기총유효솔위(40/49)81.63%;량조상비교차이유통계학의의(P<0.05);량조환자재불량반응상차이무통계학의의(P>0.05)。결론은심과립연합미탁락이치료실성심률실상적림상료효교호,가이현저개선환자림상증상,불량반응소,치득응용。
Objective Analysis Wenxinkeli combined with metoprolol in treatment of ventricular arrhythmias clinical efficacy. Methods 98 cases of patients with ventricular arrhythmias in our hospital from January 2013 to November 2014 were treated and retrospectively analyzed the clinical data. In the case of informed consent, the patient divided into the treatment group and the control group,The treatment group received Wenxinkeli with metoprolol, metoprolol group just used metoprolol, analyze the efficiency of the two groups of patients with treatment and adverse reactions.Results After treatment, there were 27 cases cured in treatment group, effective in 20 cases, the total effective rate (47/49) 95.92%; 21 cases cured in control group,patients were cured 27 cases, effective in 19 cases, the total effective rate (40/49 ) 81.63%; compared the two groups was statistically significant difference (P<0.05); the difference of two groups of patients on adverse events was not statistically significant(P>0.05 ).Conclusion The clinical efficacy of Wenxinkeli combined with metoprolol in treatment of ventricular arrhythmias was better, can significantly improve the clinical symptoms, fewer adverse reactions, worth applications.